PFM Health Sciences’s Revvity RVTY Stock Holding History

PFM Health Sciences’s Portfolio RVTY Stock Details RVTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-147,000	Closed	-$18.4M	–	102
2020 Q3	$18.4M	Buy	+147,000	New	+$16.9M	0.85%	43
2019 Q3	–	Sell	-213,370	Closed	-$20.6M	–	98
2019 Q2	$20.6M	Sell	213,370 -259,286	-55%	-$24.2M	0.39%	63
2019 Q1	$45.5M	Buy	+472,656	New	+$42.6M	1.01%	34
2018 Q4	–	Sell	-693,791	Closed	-$67.5M	–	119
2018 Q3	$67.5M	Sell	693,791 -468,026	-40%	-$40.2M	0.99%	41
2018 Q2	$85.1M	Buy	1,161,817 +80,310	+7%	+$6.02M	1.33%	21
2018 Q1	$81.9M	Buy	1,081,507 +183,347	+20%	+$14.2M	1.66%	19
2017 Q4	$65.7M	Buy	898,160 +223,893	+33%	+$16.1M	1.56%	24
2017 Q3	$46.5M	Buy	674,267 +85,727	+15%	+$5.75M	0.91%	43
2017 Q2	$40.1M	Buy	+588,540	New	+$36.6M	1.08%	33
2014 Q2	–	Sell	-116,477	Closed	-$5.25M	–	76
2014 Q1	$5.25M	Buy	+116,477	New	+$5.11M	0.1%	67

Other funds holding RVTY

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

PFM Health Sciences's RVTY Position: Q4 2020 in Review

PFM Health Sciences sold out of Revvity (RVTY) in Q4 2020, closing a stake of 147,000 shares — an estimated $18.4M sold.

PFM Health Sciences first reported a position in RVTY in Q1 2014 and held it in 10 quarters. The position peaked at $85.1M in Q2 2018. 597 funds tracked by Wall St. Rank hold RVTY as of Q4 2020.

PFM Health Sciences reported no remaining Revvity position as of Q4 2020 after selling out during the quarter.
PFM Health Sciences sold 147,000 Revvity shares in Q4 2020, an estimated $18.4M.
PFM Health Sciences first reported a position in Revvity in Q1 2014 and held it in 10 quarters.
PFM Health Sciences's Revvity position peaked at $85.1M in Q2 2018.
597 funds tracked by Wall St. Rank held Revvity as of Q4 2020.

Based on PFM Health Sciences's 13F filing for Q4 2020, filed 16 Feb 2021.